Actinogen Medical Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Stock Symbol
  • ACW
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.02
  • (As of Friday Closing)

Actinogen Medical General Information

Description

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological and metabolic diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem and it is currently in Phase II.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
ASX
Primary Office
  • Level 9, Suite 1
  • 68 Pitt Street
  • Sydney, New South Wales 2000
  • Australia
+61 (02) 0000 0000

Actinogen Medical Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Actinogen Medical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $24.6M 1.45B 9.1M

Actinogen Medical Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 13,764 13,678 (3,066) 20,620
EBITDA (2,228) (3,338) (6,958) (4,572)
Net Income (2,509) (3,570) (7,070) (4,826)
Total Assets 12,737 8,202 11,361 13,242
Total Debt 267 268 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Actinogen Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Actinogen Medical‘s full profile, request access.

Request a free trial

Actinogen Medical Executive Team (1)

Name Title Board Seat Contact Info
Bill Ketelbey Chief Executive Officer & Managing Director
To view Actinogen Medical’s complete executive team members history, request access »

Actinogen Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Actinogen Medical‘s full profile, request access.

Request a free trial

Actinogen Medical Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 17-Oct-2011 000000000000000000 Biotechnology
To view Actinogen Medical’s complete acquisitions history, request access »